In breast cancer treatment, several key molecular targets have been identified, including human epidermal growth factor receptor 2, vascular endothelial growth factor, folate receptors, somatostatin receptors, vascular endothelial cell adhesion molecules, estrogen receptors, and cyclooxygenase-2 (97). Here, ESR1 is linked to breast carcinoma.